Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification (Ro-SjS)
Clinical trial NCT07414667 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07414667
- Sponsor
- Central Hospital, Nancy, France
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-01
- Primary completion
- 2026-12-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.